Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aclaris Therapeutics (ACRS) Non Operating Income: 2015-2024

Historic Non Operating Income for Aclaris Therapeutics (ACRS) over the last 10 years, with Dec 2024 value amounting to $9.9 million.

  • Aclaris Therapeutics' Non Operating Income fell 12.13% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 30.27%. This contributed to the annual value of $9.9 million for FY2024, which is 15.96% up from last year.
  • According to the latest figures from FY2024, Aclaris Therapeutics' Non Operating Income is $9.9 million, which was up 15.96% from $8.5 million recorded in FY2023.
  • Aclaris Therapeutics' 5-year Non Operating Income high stood at $9.9 million for FY2024, and its period low was -$1.1 million during FY2021.
  • Moreover, its 3-year median value for Non Operating Income was $8.5 million (2023), whereas its average is $7.1 million.
  • As far as peak fluctuations go, Aclaris Therapeutics' Non Operating Income plummeted by 169.34% in 2021, and later skyrocketed by 357.97% in 2022.
  • Yearly analysis of 5 years shows Aclaris Therapeutics' Non Operating Income stood at -$424,000 in 2020, then crashed by 169.34% to -$1.1 million in 2021, then soared by 357.97% to $2.9 million in 2022, then surged by 188.83% to $8.5 million in 2023, then increased by 15.96% to $9.9 million in 2024.